tolvaptan

FDA Drug Profile — Jynarque, JYNARQUE, SAMSCA, tolvaptan

tolvaptan is listed in the FDA National Drug Code directory with 20 NDC codes, marketed under brand names including Jynarque, JYNARQUE, SAMSCA. Available dosage forms: kit, tablet.

Drug details

Generic Name
tolvaptan
Brand Names
Jynarque, JYNARQUE, SAMSCA, tolvaptan
Application Number
NDA204441
Sponsor
Otsuka America Pharmaceutical, Inc.
NDC Codes
20
Dosage Forms
KIT, TABLET
Routes
ORAL
Active Ingredients
TOLVAPTAN

Indications and Usage

1 INDICATIONS & USAGE Tolvaptan tablet is indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD). Tolvaptan tablet is a selective vasopressin V 2 -receptor antagonist indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD) ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.